Changes in regional hemodynamics after nitric oxide inhibition during ovine bacteremia

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 270, Issue 1 39-1, 1996, Pages

  Lingnau, Werner ^a   McGuire, Roy ^a   Behring, Deborah J ^a   Traber, Lillian D ^a   Linares, Hugo A ^a   Nelson, Sharon H ^a   Kilbourn, Robert G ^a   Traber, Daniel L ^a,b  

^a SHRINERS HOSPITALS FOR CHILDREN   (United States)

^b University of Texas Medical Branch School of Medicine   (United States)

Author keywords

blood flow; methyl arginine; N( ) nitro L arginine methyl ester; N( ) monomethyl L arginine; nitric oxide synthase inhibition; Pseudomonas

Indexed keywords

N(G) METHYLARGININE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY BLOOD FLOW; ARTICLE; BACTEREMIA; BOLUS INJECTION; BRAIN BLOOD FLOW; CARDIOVASCULAR RESPONSE; COLONY FORMING UNIT; CONTINUOUS INFUSION; CONTROLLED STUDY; DOSE RESPONSE; DRUG BLOOD LEVEL; ENZYME INHIBITION; FEMALE; HEART INDEX; HEART OUTPUT; HEMODYNAMICS; INTRAVENOUS DRUG ADMINISTRATION; LIMB BLOOD FLOW; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SEPSIS; SHEEP; SYSTEMIC VASCULAR RESISTANCE;

EID: 0030051646     PISSN: 03636119     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpregu.1996.270.1.r207     Document Type: Article

References (36)

1. G-nitro-L-arginine in rat aorta (Abstract). Pharmacologist 34: 147, 1992.
2. Balligand, J. L., D. Ungureanu, R. A. Kelly, L. Kobzik, D. Pimental, T. Michel, and T. W. Smith. Abnormal contractile function due to induction of nitric oxide synthesis in rat cardiac myocytes follows exposure to activated macrophage-conditioned medium. J. Clin. Invest. 91: 2314-2319, 1993.
3. Brady, A. J., J. B. Warren, P. A. Poole Wilson, T. J. Williams, and S. E. Harding. Nitric oxide attenuates cardiac myocyte contraction. Am. J. Physiol. 265 (Heart Circ. Physiol. 34): H176-H182, 1993.
4. Busse, R., and A. Mulsch. Induction of nitric oxide synthase by cytokines in vascular smooth muscle cells. FEBS Lett. 275: 87-90, 1990.
5. ω-amino-L-arginine, an inhibitor of nitric oxide synthase, raises vascular resistance but increases mortality rates in awake canines challenged with endotoxin. J. Exp. Med. 176: 1175-1182, 1992.
6. Dehring, D. J., R. C. Fader, L. D. Traber, and D. L. Traber. Cardiopulmonary changes occurring with pulmonary intravascular clearance of live bacteria in sheep. Circ. Shock 29: 245-256, 1989.
7. Forstermann, U., H. H. Schmidt, J. S. Pollock, H. Sheng, J. A. Mitchell, T. D. Warner, M. Nakane, and F. Murad. Isoforms of nitric oxide synthase. Characterization and purification from different cell types. Biochem. Pharmacol. 42: 1849-1857, 1991.
8. Furchgott, R. F., and J. V. Zawadzki. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature Lond. 288: 373-376, 1980.
9. Gardiner, S. M., A. M. Compton, T. Bennett, R. M. Palmer, and S. Moncada. Control of regional blood flow by endothelium-derived nitric oxide. Hypertension Dallas 15: 486-492, 1990
10. Gray, G. A., C. Schott, G. Julou-Schaeffer, I. Fleming, J. R. Parratt, and J. C. Stoclet. The effect of inhibitors of the L-arginine/nitric oxide pathway on endotoxin-induced loss of vascular responsiveness in anaesthetized rats. Br. J. Pharmacol. 103: 1218-1224, 1991.
11. Green, S. J., M. S. Meltzer, J. B. Hibbs, and C. A. Nacy. Activated macrophages destroy intracellular Leishmania major amastigotes by an L-arginine-dependent killing mechanism. J. Immunol. 144: 278-283, 1990.
12. Gross, S. S., E. A. Jaffe, R. Levi, and R. G. Kilbourn. Cytokine-activated endothelial cells express an isotype of nitric oxide synthase which is tetrahydrobiopterin-dependent, calmodulin-independent and inhibited by arginine analogs with a rank-order of potency characteristic of activated macrophages. Biochem. Biophys. Res. Commun. 178: 823-829, 1991.
13. Guyton, A. C., C. E. Jones, and T. G. Coleman. Normal cardiac output and its variations. In: Cardiac Physiology: Cardiac Output and Its Regulation. Philadelphia, PA: Saunders, 1973, p. 3-20.
14. G-monomethyl-L-arginine to L-citrulline and subsequently to L-arginine. Biochem. Biophys. Res. Commun. 167: 1037-1043, 1990.
15. Kilbourn, R. G., and P. Belloni. Endothelial cell production of nitrogen oxides in response to interferon gamma in combination with tumor necrosis factor, interleukin-1, or endotoxin. J. Natl. Cancer Inst. 82: 772-776, 1990.
16. G-methyl-L-arginine inhibits tumor necrosis factor-induced hypotension: implications for the involvement of nitric oxide Proc. Natl. Acad. Sci. USA 87: 3629-3632, 1990.
17. G-methyl-L-arginine, an inhibitor of nitric oxide synthesis. Biochem. Biophys. Res. Commun. 172: 1132-1138, 1990.
18. Loeb, A. L., and D. E. Longnecker. Inhibition of endothelium-derived relaxing factor-dependent circulatory control in intact rats Am. J. Physiol. 262 (Heart Circ. Physiol. 31): H1494-H1500, 1992.
19. MacNaul, K. L., and N. I. Hutchinson. Differential expression of iNOS and cNOS mRNA in human vascular smooth muscle cells and endothelial cells under normal and inflammatory conditions. Biochem. Biophys. Res. Commun. 196: 1330-1334, 1993.
20. 19a.Meyer, J., F. Hinder, J. Stothert, L. D. Traber, D. Herndon, J. T. Flynn, and D. L. Traber. Increased organ blood flow in chronic endotoxemia is reversed by nitric oxide synthase inhibition. J. Appl. Physiol. 76, 2785-2793, 1994.
21. Meyer, J., L. D. Traber, S. Nelson, C. W. Lentz, H. Nakazawa, D. N. Herndon, H. Noda, and D. L. Traber. Reversal of hyperdynamic response to continuous endotoxin administration by inhibition of NO synthesis. J Appl. Physiol. 73: 324-328, 1992.
22. Moncada, S., R. M. Palmer, and E. A. Higgs. The discovery of nitric oxide as the endogenous nitrovasodilator. Hypertension Dallas 12: 365-372, 1988.
23. Myers, P. R., T. F. Wright, M. A. Tanner, and H. R. Adams. EDRF and nitric oxide production in cultured endothelial cells: direct inhibition by E. coli endotoxin. Am. J. Physiol. 262 (Heart Circ. Physiol. 31): H710-H718, 1992.
24. Nathan, C. F., and J. B. Hibbs. Role of nitric oxide synthesis in macrophage antimicrobial activity. Curr. Opin. Immunol. 3: 65-70, 1991.
25. Parker, J. L., and H. R. Adams. Selective inhibition of endothelium-dependent vasodilator capacity by Eacherichia coli endotoxemia. Circ. Res. 72: 539-551, 1993.
26. Rees, D. D., R. M. Palmer, and S. Moncada. Role of endothelium-derived nitric oxide in the regulation of blood pressure. Proc. Natl Acad. Sci. USA 86: 3375-3378, 1989.
27. Salvemini, D., E. Masini, E. Anggard, P. F. Mannaioni, and J. Vane. Synthesis of a nitric oxide-like factor from L-arginine by rat serosal mast cells: stimulation of guanylate cyclase and inhibition of platelet aggregation. Biochem. Biophys. Res. Commun 169: 596-601, 1990.
28. Shoemaker, W. C., P. L. Appel, H. B. Kram, K. Waxman, and T. S. Lee. Prospective trial of supranormal values of survivors as therapeutic goals in high-risk surgical patients. Chest 94: 1176-1186, 1988.
29. Sigmon, D. H., and W. H. Beierwaltes. Angiotensin II: nitric oxide interaction and the distribution of blood flow. Am. J. Physiol. 265 (Regulatory Integrative Comp. Physiol. 34): R1276-R1283, 1993.
30. Slocum, R. H., and J. G. Cummings. Amino acid analysis of physiological samples. In: Techniques in Diagnostic Human Biochemical Genetics: A Laboratory Manual, edited by F. A. Hommes. New York: Wiley-Liss, 1991, p. 87-126.
31. Spath, J. A., P. J. Sloane, M. H. Gee, and K. H. Albertine. Loss of endothelium-dependent vasodilation in the pulmonary vessels of sheep after prolonged endotoxin. J. Appl. Physiol. 76: 361-369, 1994.
32. Stuehr, D. J., and M. A. Marletta. Synthesis of nitrite and nitrate in murine macrophage cell lines. Cancer Res. 47: 5590-5594, 1987.
33. Suffredini, A. F., R. E. Fromm, M. M. Parker, M. Brenner, J. A. Kovacs, R. A. Wesley, and J. E. Parrillo. The cardiovascular response of normal humans to the administration of endotoxin. N. Engl. J. Med. 321: 280-287, 1989.
34. ω-nitro-L-arginine in rats. Br. J. Pharmacol. 111: 394-396, 1994.
35. Wang, Y. X., I. Gavras, T. Wierzba, B. Lammek, and H. Gavras. Inhibition of nitric oxide, bradykinin, and prostaglandins in normal rats. Hypertension Dallas 19, Suppl. II: II-255-II-261, 1992.
36. G-substituted arginines on coronary vascular function after endotoxin. J. Appl. Physiol. 75: 424-431, 1993